New strategies for the synthesis of A3 adenosine receptor antagonists

被引:61
作者
Baraldi, PG
Bovero, A
Fruttarolo, F
Romagnoli, R
Tabrizi, MA
Preti, D
Varani, K
Borea, PA
Moorman, AR
机构
[1] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[2] Univ Ferrara, Sez Farmacol, Dipartimento Med Clin & Sperimentale, I-44100 Ferrara, Italy
[3] King Pharmaceut Res & Dev, Cary, NC 27513 USA
关键词
D O I
10.1016/S0968-0896(03)00484-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New A(3) adenosine receptor antagonists were synthesized and tested at human adenosine receptor subtypes. An advanced synthetic strategy permitted us to obtain a large amount of the key intermediate 5 that was then submitted to alkylation procedures in order to obtain the derivatives 6-8. These compounds were then functionalised into ureas at the 5-position (compounds 9-11, 18 and 19) to evaluate their affinity and selectivity versus hA(3) adenosine receptor subtype, in particular, compounds 18 and 19 displayed a value of affinity of 4.9 and 1.3 nM, respectively. Starting from 5, the synthetic methodologies employed permitted us to perform a rapid and a convenient divergent synthesis. A further improvement allowed the regioselective preparation of the N-8-substituted compound 7. This method could be used as an helpful general procedure for the design of novel A3 adenosine receptor antagonists without the difficulty of separating the N8-substituted pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines from the corresponding NI-isomers. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4161 / 4169
页数:9
相关论文
共 20 条
[1]  
Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038
[2]  
Ali H, 1996, J PHARMACOL EXP THER, V276, P837
[3]   Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists:: Influence of the chain at the N8 pyrazole nitrogen [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Spalluto, G ;
Moro, S ;
Klotz, KN ;
Leung, E ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4768-4780
[4]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780
[5]   Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Spalluto, G ;
Klotz, KN ;
Leung, E ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) :4473-4478
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Activation of the A3 adenosine receptor affects cell cycle progression and cell growth [J].
Brambilla, R ;
Cattabeni, F ;
Ceruti, S ;
Barbieri, D ;
Franceschi, C ;
Kim, YC ;
Jacobson, KA ;
Klotz, KN ;
Lohse, MJ ;
Abbracchio, MP .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (03) :225-234
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]  
DUNN LD, 1975, J ORG CHEM, V40, P3713
[10]   Structure and function of adenosine receptors and their genes [J].
Fredholm, BB ;
Arslan, G ;
Halldner, L ;
Kull, B ;
Schulte, G ;
Wasserman, W .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (4-5) :364-374